Working at the Sanger Institute is truly unique. We put collaboration, innovation and support for people as individuals at the centre of everything we do. Join us to help shape the future by delivering life-changing science with the reach, scale, and creativity to solve some of humanity’s greatest challenges.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We are committed to training the next generation of pioneering genome scientists and clinicians. At the Wellome Sanger Institute we give PhD students and postdocs all the tools they need to succeed in the field of genomics research.
Our vision and mission is to deliver world-leading genomics research in collaboration with research partners across the globe. Discover how our funding gives our leadership the independence to conduct bold, ambitious science that pioneers new fields in health, disease and conservation.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
By focusing on fundamental discovery research led by our faculty and employing our unique scale in cutting-edge data generation and analysis, we deliver discoveries not easily made elsewhere.
From providing fundamental resources for understanding biology to exploring cancer genomes and the effects of variation in human genomes, our work lays the foundations for personalised medicine. We also reveal the secrets of human development and how infectious diseases evolve and spread.
Discover how our leadership and structures are designed to enable holistic and effective decision making, with transparency and accountability woven into their make up.
The diversity in skills and knowledge that we all bring make our Institute the thriving ideas factory that it is. Discover how we support each other to reach our full potential and thrive. We celebrate diversity and seek to ensure that everyone has equal access to professional and career development opportunities.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We play a pivotal role in helping to shape Government and International research policies. We also lead the way in developing guidance to support our scientists to carry out their research ethically, equitably and responsibly.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We are sited on the Wellcome Genome Campus at the very heart of a global hub of fundamental and applied genomic research, education and engagement. It is home to some of the world’s foremost institutes and organisations using genomes and biodata to deliver science with the reach, scale and imagination to solve some of humanity’s greatest challenges and maximise societal benefit.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
Our research is organised into six primary Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. In addition, our Associate Research programmes pioneer new approaches to studying health and disease.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
The Sanger Institute has published papers in some of the most prestigious scientific journals. We aim to publish research that will transform biology and improve healthcare.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Sanger Institute’s Research Policies are designed to provide guidance to help researchers navigate the legislation relating to their research and to ensure that research is ethical and legal.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
The Sanger Institute played a major role in the genomic surveillance of the COVID-19 pandemic, providing large-scale high-throughput sequencing of the SARS-CoV-2 virus and analysis of its evolution and spread in the UK.
Throughout the COVID-19 lockdown of 2020-2021 we hosted a series of monthly freely available and open virtual seminars. From using genomic approaches to map all cell types in the human body, understand how cancer develops, and track the evolution and spread of global diseases, our senior scientists and faculty presented the latest developments in their field.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease or analytic focus. In all cases, the studies provide insights into human, pathogen, cellular evolution, the phenotypic and hence biological consequences of genome variation and the processes which cause mutations.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is founded on the talents, imagination and curiosity of our people. Our wet-lab scientists, bioinformaticians, developers, engineers and skilled administrators work together to deliver cutting-edge research. Join us Read more
The Sanger Leadership Team is an Executive Committee that enables holistic and effective decision making, with transparency and accountability woven into its make up.
We draw on a number of experienced and internationally recognised scientists to provide independent scientific support, advice and challenge to help us maintain our scientific excellence.
Our science is founded on the talents, imagination and curiosity of our people. Our wet-lab scientists, bioinformaticians, developers, engineers and skilled administrators work together to deliver cutting-edge research. Join us Read more
Our Faculty conceive and deliver our science. Within our strategic framework the Institute’s scientific aspirations are driven by their vision, imagination and intellectual energy.
Our Associate Faculty combine their skills and knowledge with the Sanger Institute’s unique abilities to conduct data generation and analysis at scale to pioneer genomic research in new areas.
Almost 1,000 scientists, developers, engineers and skilled professionals work together to deliver the Sanger Institute’s cutting-edge genomic research.
Our science is founded on the talents, imagination and curiosity of our people. Our wet-lab scientists, bioinformaticians, developers, engineers and skilled administrators work together to deliver cutting-edge research. Join us Read more
From PhD students and Postdoctoral Fellows, bioinformaticians and laboratory managers, search for our staff who the support the delivery of pioneering science.
Almost 1,000 scientists, developers, engineers and skilled professionals work together to deliver the Sanger Institute’s cutting-edge genomic research.
Our science is founded on the talents, imagination and curiosity of our people. Our wet-lab scientists, bioinformaticians, developers, engineers and skilled administrators work together to deliver cutting-edge research. Join us Read more
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
Find out how our translation team maximises the socioeconomic impact of the Sanger Institute’s discoveries by translating our science into products, services and technologies that benefit patients in a variety of settings.
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
Read how we benefit society by buiding on the innovative capabilities of our people by engaging with businesses and creating commercial opportunities. We also develop a unique and vibrant ecosystem to establish and grow innovative genomics and biodata businesses.
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
Read examples of how we engage with funding, R&D, service and clinical communities to promote real-world utilisation of the Sanger Institute’s technologies and resources.
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
The Communications team promote the Sanger Institute’s research and discoveries, using both traditional media such as print, radio interviews and TV footage and social media like Twitter, Facebook and the Sanger Institute blog
The finished human genome The International Human Genome Sequencing Consortium, of which the Wellcome Trust Sanger Institute is a major partner, today published their scientific analysis of the finished human genome, the Gold Standard sequence that is already acting to prime new biomedical research.
The paper is published on 21 October 2004 in Nature and details the rigorous standards set and surpassed during the 13-year Human Genome Project (HGP). The analysis suggests that there are perhaps only 20,000-25,000 protein-coding genes in our human genome.
The Wellcome Trust Sanger Institute made the largest single contribution to the human genome sequence and the ‘genome browser’ ENSEMBL, run by the Sanger Institute and the EMBL-European Bioinformatics Institute is a leading resource for researchers around the globe.
Key results of the research are:
The number of gaps has been reduced 400-fold to only 341
The finished human genome It covers 99 per cent of the gene-containing parts of the genome and is 99.999 per cent accurate
The new sequence correctly identifies almost all known genes (99.74 per cent)
It defines 22,287 ‘gene loci’, consisting of 19,599 protein-coding genes in the human genome and another 2,188 DNA segments that are predicted to be protein-coding genes
It identifies the ‘birth’ of 1183 genes in the last 60-100 million years
It identifies the ‘death’ of 30 or so genes in a similar time period
The accuracy and completeness allows systematic searches for the causes of disease, for example, to find all key heritable factors predisposing to diabetes or mutations underlying breast cancer – with confidence that little can escape detection
At a practical level, it eliminates tedious confirmatory work by researchers, who can now rely on highly accurate information
More generally, the HGP demonstrates the tremendous potential value of coordinated projects to create community resources to propel biomedical research
“In our analysis we revised some predictions based on the unfinished, draft sequence of the human genome. The task of identifying genes remains challenging, but the finished human genome sequence, genome sequences from other organisms, better computational models and other improved resources, have combined to give a much clearer and more reliable picture of our genomic landscape.”
Dr Jane Rogers Head of Sequencing at the Wellcome Trust Sanger Institute
The quality of sequence produced has an estimated error rate of less than one per 100,000 bases of code – tenfold better than the original goal. This means that gene identification can be more reliable and that studies our genome and health – for example, what genetic changes mean some individuals are predisposed to disease – can be carried out with greater confidence.
“Only a decade ago, most scientists thought humans had about 100,000 genes. When we analyzed the working draft of the human genome sequence three years ago, we estimated there were about 30,000 to 35,000 genes, which surprised many. This new analysis reduces that number even further and provides us with the clearest picture yet of our genome. The availability of the highly accurate human genome sequence in free public databases enables researchers around the world to conduct even more precise studies of our genetic instruction book and how it influences health and disease.”
NHGRI Director Francis S. Collins MD, PhD
Key challenges that lie ahead include: a systematic study of sequence variation among humans in a study of the association of variation with disease; systematic identification of non-protein-coding elements in the human genome, especially regulatory controls and structure elements; systematic identification of all the ‘modules’ in which genes and proteins function together to place genetic information in a functional context.
“Collectively we have produced a sequence that is as accurate and complete as possible in the present state of the art. It will be open for continuous improvement over the years to come, and of course open for all to use for any purpose, without restraint or fee. Let us continue to work together to ensure that the enormous benefits from this new knowledge flow to all and not just to the few.”
Sir John Sulston Former Director of The Wellcome Trust Sanger Institute
More information
More than 2,800 researchers who took part in the International Human Genome Sequencing Consortium share authorship on today’s Nature paper, which expands upon the group’s initial analysis published in Feb. 2001. Even more detailed annotations and analyses have already been published for chromosomes 5, 6, 7, 9, 10, 13, 14, 19, 20, 21, 22 and Y. Publications describing the remaining 12 chromosomes are forthcoming.
The finished human genome sequence and its annotations can be accessed through the following public genome browsers: the Ensembl Genome Browser (www.ensembl.org) at the Wellcome Trust Sanger Institute and the EMBL-European Bioinformatics Institute; GenBank (www.ncbi.nih.gov/Genbank) at NIH’s National Center for Biotechnology Information (NCBI); the UCSC Genome Browser (www.genome.ucsc.edu) at the University of California at Santa Cruz; EMBL-Bank (www.ebi.ac.uk/embl) at the EMBL-European Bioinformatics Institute; and the DNA Data Bank of Japan (www.ddbj.nig.ac.jp)
The International Human Genome Sequencing Consortium includes scientists at 20 institutions located in France, Germany, Japan, China, the United Kingdom and the United States.
The Wellcome Trust Sanger Institute, which receives the majority of its funding from the Wellcome Trust, was founded in 1992. The Institute is responsible for the completion of the sequence of approximately one-third of the human genome as well as genomes of model organisms and more than 90 pathogen genomes. In October 2006, new funding was awarded by the Wellcome Trust to exploit the wealth of genome data now available to answer important questions about health and disease.
The Wellcome Trust is the most diverse biomedical research charity in the world, spending about £450 million every year both in the UK and internationally to support and promote research that will improve the health of humans and animals. The Trust was established under the will of Sir Henry Wellcome, and is funded from a private endowment, which is managed with long-term stability and growth in mind.